Fig. 1From: Response to post-axitinib treatment in patients with metastatic renal cell carcinomaTreatment Duration with Axitinib vs First Subsequent (Post – Axitinib) Systemic Therapy. Notes: Axitinib duration cropped at 30 months for two patients (actual durations were 53.1 and 90.0 months). Data points above the diagonal represent patients who remained on treatment longer with subsequent therapy than with axitinib; points below the diagonal represent the converseBack to article page